← Back to Search

Antioxidant

Nutritional Supplements Group for Vestibular Disease

Phase < 1
Waitlist Available
Led By Brian Perry, MD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights

Study Summary

This trial will look at whether taking antioxidants can help improve balance in older adults.

Eligible Conditions
  • Vestibular Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Slow Harmonic Acceleration
Secondary outcome measures
Number of falls
Step Velocity Test
Tolerance of supplements

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Nutritional Supplements GroupExperimental Treatment2 Interventions
Alpha Lipoic Acid will be administered as two 300 mg capsules taken once daily CoQ-10 will be administered as two 200mg capsules daily.
Group II: Standard of Care GroupActive Control1 Intervention
Standard of care treatment for vestibular function.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
452 Previous Clinical Trials
91,414 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,005,064 Total Patients Enrolled
Brian Perry, MDPrincipal InvestigatorUniversity of Texas Health Science Center San Antonio

Media Library

Alpha Lipoic Acid (Antioxidant) Clinical Trial Eligibility Overview. Trial Name: NCT05945160 — Phase < 1
Vestibular Disease Research Study Groups: Standard of Care Group, Nutritional Supplements Group
Vestibular Disease Clinical Trial 2023: Alpha Lipoic Acid Highlights & Side Effects. Trial Name: NCT05945160 — Phase < 1
Alpha Lipoic Acid (Antioxidant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05945160 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age restriction when considering candidates for this trial?

"As per the trial's specified inclusion criteria, potential participants must be between 65 and 90 years old."

Answered by AI

Is the research team currently looking to enroll more participants?

"According to the clinicaltrials.gov website, this experiment has ceased recruitment for now; it was initially posted on August 1st 2023 and its most recent update occurred on July 5th 2023. However, there are currently 32 other studies actively looking for volunteers."

Answered by AI

Who qualifies to join this research endeavor?

"In order to join this trial, applicants should have a diagnosed vestibular disorder and be aged between 65 to 90. Approximately 50 participants are needed for the study."

Answered by AI
~0 spots leftby Aug 2024